BBC Report Covers Demands from Health Activists.

Dec.14.2022
BBC Report Covers Demands from Health Activists.
BBC report covers ASH's demands to restrict nicotine pouch sales to minors and regulate product strength and marketing.

A report by the BBC has highlighted demands from health campaigners to the government. The report quoted Hazel Cheeseman, spokesperson for Action on Smoking and Health (ASH), who called on the current government to "ban free samples and sales to those under 18, introduce strength limits, and restrict the marketing of small packets.


The New Nicotine Alliance commented, "Although there is no age restriction on the sale of pouches, technically it is not a loophole but rather a lack of regulation because pouches are already regulated under the General Product Safety Regulations and do not have their own regulatory framework." The NNA expressed its approval of some proposals made by the BBC.


In February and August of 2020, we wrote to Health Secretary Matt Hancock regarding regulation of nicotine pouches, and in January of 2021, we wrote again to Public Health Minister Jo Churchill to discuss the issue. Our letters emphasized the potential benefits of nicotine pouches but also pointed out the need for regulations to combat "unscrupulous sellers operating with impunity in the UK.


We also note that although there is 'no evidence that these nicotine pouches are currently in the hands of those under the age of 18,' it is necessary to establish a minimum sales age to prevent any difficulties that may arise in the absence of nicotine. It is clear that these products are designed for adults who wish to use safer nicotine products.


The New Nicotine Alliance has proposed that the government instruct the Committee on Toxicity (COT) to conduct a comprehensive toxicological study to evaluate the potential benefits of nicotine pouches, similar to what has been done for tobacco products such as electronic cigarettes and heated products.


The report has been commissioned and the initial draft was released in July of this year. A similar process has also taken place in Germany, where the German Federal Institute for Risk Assessment (BfR) conducted a toxicological assessment of the bags and came to positive conclusions, the consumer group continued to say.


We also agree that there should be a clear limit on the strength of nicotine pouches, as well as a standard measure for consumers to understand the strength of the product they are buying, since currently different manufacturers convey product strength in different ways.


We know that nicotine strength is not the only factor in how consumers safely consume nicotine from pouches and non-tobacco products. Manufacturing quality and ingredients also play a role. However, until more complex regulatory evaluations of all these factors can be implemented, the set restrictions can serve as a wise barrier to help drive unregulated and irresponsible online sellers out of the market.


Our friends at ETHRA have informed us that this is not unprecedented in Europe. In October, the Slovakian parliament unanimously passed legislation regulating nicotine pouches. The legislation introduced a definition for nicotine pouches, regulated their composition, mandated health warnings, set a nicotine limit of 20mg per pouch, and implemented other measures.


The New Nicotine Alliance disagrees with the proposal to ban samples. They believe that if smokers are not intending to switch to vaping or quit smoking through other means, offering small packs is a useful way to encourage them to do so.


The latest report from the "Smoking and Health Action" regarding e-cigarette use in the UK has revealed that only 3.9% of the public have tried nicotine pouches. In order to truly progress towards a smoke-free 2030, it is important to educate the public on all of the low-risk options for nicotine delivery, and banning advertising for them when over 14% of the adult population still smokes serves no benefit.


In the letter we sent to the Department of Health, we outlined our overall strategy to reduce harm in the UK, as well as our recent independent tobacco review, in which we recommended the establishment of a regulatory framework for nicotine pouches and other non-tobacco oral products based on consumer welfare and the protection of nicotine products.


We are glad to see that some of our long-standing recommendations on regulating nicotine pouches have been adopted by health groups. However, it is important that the government does not go too far with excessive regulation that could harm the potential benefits of the product. We don't want to lose sight of the goal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
Australian authorities have disclosed two major enforcement actions that go beyond product seizures and retail closures to examine how illicit tobacco and vape networks operate. On Aug. 14, the Multi Agency Strike Team said seven people had been charged and two criminal networks were valued by authorities at a combined A$80 million, or about US$56.8 million. Investigators allege the groups used bonded warehouses, freight businesses and “trusted insiders” in legitimate industries to circumvent border controls. In a separate operation on Aug. 11, more than 100 service stations were targeted as authorities sought information on illicit tobacco importation, distribution networks and the movement of sales proceeds.
Aug.17